Clinical Trials Directory

Trials / Completed

CompletedNCT06906510

Evaluation of Trimethylamine N-oxide (TMAO) Levels in Periodontal Disease

Status
Completed
Phase
Study type
Observational
Enrollment
48 (actual)
Sponsor
Ankara Medipol University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Salivary and serum levels of TMAO and TNF-α can distinguish between individuals with periodontitis and periodontally healthy individuals.

Detailed description

Trimethylamine N-oxide (TMAO), a gut flora-derived metabolite from dietary choline, has emerged as an indicator of atherosclerosis. Circulatory TMAO has been implicated in cardiovascular risks by altering enterohepatic cholesterol and bile acid metabolism, increasing macrophage scavenger receptor expression, and activating nuclear factor kappa B (NF-κB) via pro-inflammatory genes such as interleukin-1 (IL-1). The pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-α), which plays a crucial role in immune responses and inflammation, has been demonstrated as a crucial participant also during the development of periodontal diseases. The aim of this study is to evaluate difference in salivary and serum levels of TMAO and TNF-α between individuals with periodontitis and periodontally healthy individuals. The study includes two groups: systemically and periodontally healthy control subjects (n= 24), and patients with periodontitis (n=24). Periodontal parameters were recorded. TMAO levels in saliva and serum were determined by liquid chromatography-mass spectrometry (LC-MS/MS), and TNF-α levels were determined by ELISA.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSalivary and Serum TMAO MesurementSalivary and serum TMAO levels were measured by liquid chromatography-mass spectrometry (LC-MS/MS)
DIAGNOSTIC_TESTSalivary and Serum TNF-α MesurementSalivary and serum TNF-α levels were measured by ELISA

Timeline

Start date
2024-01-08
Primary completion
2024-08-14
Completion
2024-09-23
First posted
2025-04-02
Last updated
2025-04-02

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06906510. Inclusion in this directory is not an endorsement.